By vgreene, 3 April, 2020 A Phase 2, International Multi-site, Bayesian Adaptive, Randomized, Double-blinded, Placebo-controlled Trial Assessing the Effectiveness of Varied Doses of Oral Chloroquine in Preventing or Reducing the Severity of COVID-19 Disease in Healthcare Workers,
By vgreene, 3 April, 2020 A Phase II Pilot Study of Quintuple Therapy to Treat COVID-19 Infection, NCT04334512
By vgreene, 3 April, 2020 Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease, NCT04332991
By vgreene, 3 April, 2020 A Prospective Clinical Study of Hydroxychloroquine in the Prevention of SARS-CoV-2 (COVID-19) Infection in Healthcare Workers After High-risk Exposures, NCT04333225
By vgreene, 3 April, 2020 Potential drug interactions: CYP1A2 substrates (may inhibit),14 3A4 substrates (may induce),15 immunosuppressants (may antagonize)16